Synapse - Robert Motzer

Results (160)

mTOR inhibitor therapy for metastatic sarcomatoid clear cell renal cell carcinoma (ccRCC)

Meeting Abstract

Bastos, D. A.; Voss, M. H.; Karlo, C.; Ajeti, A.; Patil, S.; Feldman, D. R.; Molina, A. M.; Motzer, R. J.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Phase I/II study of paclitaxel plus ifosfamide (TI) followed by high-dose paclitaxel, ifosfamide, and carboplatin (TIC) with autologous stem cell transplant (ASCT) for salvage treatment of germ cell tumors (GCT)

Meeting Abstract

Jia, X.; Feldman, D. R.; Glezerman, I.; Van Alstine, L. J.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M. S.; Reich, L.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Paclitaxel, ifosfamide, and cisplatin (TIP) efficacy for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)

Meeting Abstract

Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Targeted therapy for renal cell carcinoma (RCC) with brain metastasis: Overall survival (OS) and safety

Meeting Abstract

Bastos, D. A.; Molina, A. M.; Jia, X.; Velasco, S.; Patil, S.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Pathway convergent evolution underscores treatment response to MTOR inhibitors in kidney cancers

Meeting Abstract

Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
Cancer Research (2013)

Fulltext@MSK | Save

An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma

Journal Article

Hakimi, A. A.; Furberg, H.; Zabor, E. C.; Jacobsen, A.; Schultz, N.; Ciriello, G.; Mikkilineni, N.; Fiegoli, B.; Kim, P. H.; Voss, M. H.; more...
JNCI: Journal of the National Cancer Institute (2013)

Fulltext@MSK | Save

Intra- and interobserver variability in CT measurements in oncology

Journal Article

McErlean, A.; Panicek, D. M.; Zabor, E. C.; Moskowitz, C. S.; Bitar, R.; Motzer, R. J.; Hricak, H.; Ginsberg, M. S.
Radiology (2013)

Fulltext@MSK | Save

Long-term response to sunitinib therapy for metastatic renal cell carcinoma

Journal Article

Molina, A. M.; Jia, X.; Feldman, D. R.; Hsieh, J. J.; Ginsberg, M. S.; Velasco, S.; Patil, S.; Motzer, R. J.
Clinical Genitourinary Cancer (2013)

Fulltext@MSK | Save

Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: A report by MSKCC and the KIRC TCGA research network

Journal Article

Hakimi, A. A.; Ostrovnaya, I.; Reva, B.; Schultz, N.; Chen, Y. B.; Gonen, M.; Liu, H.; Takeda, S.; Voss, M. H.; Tickoo, S. K.; more...
Clinical Cancer Research (2013)

Fulltext@MSK | Save

Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older

Journal Article

Feldman, D. R.; Voss, M. H.; Jacobsen, E. P.; Jia, X.; Suarez, J. A.; Turkula, S.; Sheinfeld, J.; Bosl, G. J.; Motzer, R. J.; Patil, S.
Cancer (2013)

Fulltext@MSK | Save